Crossref
journal-article
Elsevier BV
Immunity (78)
References
100
Referenced
803
10.1016/j.jaut.2005.09.012
/ J. Autoimmun. / The genetics of systemic lupus erythematosus by Alarcon-Riquelme (2005)10.1056/NEJMoa021933
/ N. Engl. J. Med. / Development of autoantibodies before the clinical onset of systemic lupus erythematosus by Arbuckle (2003)10.4049/jimmunol.167.4.2361
/ J. Immunol. / Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus by Arce (2001)10.1002/art.20576
/ Arthritis Rheum. / Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study by Aringer (2004)10.1073/pnas.0337679100
/ Proc. Natl. Acad. Sci. USA / Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus by Baechler (2003)10.1172/JCI750
/ J. Clin. Invest. / Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice by Balomenos (1998)10.1146/annurev.immunol.18.1.767
/ Annu. Rev. Immunol. / Immunobiology of dendritic cells by Banchereau (2000)10.1016/S1074-7613(04)00108-6
/ Immunity / Autoimmunity through cytokine-induced dendritic cell activation by Banchereau (2004)10.1084/jem.20050914
/ J. Exp. Med. / Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus by Barrat (2005)10.4049/jimmunol.171.6.3296
/ J. Immunol. / Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG by Bave (2003)10.1002/art.20998
/ Arthritis Rheum. / Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism by Bave (2005)10.1084/jem.20021553
/ J. Exp. Med. / Interferon and granulopoiesis signatures in systemic lupus erythematosus blood by Bennett (2003)10.1126/science.1064890
/ Science / Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus by Blanco (2001)10.1002/art.20745
/ Arthritis Rheum. / Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus by Blanco (2005)10.4049/jimmunol.170.1.24
/ J. Immunol. / Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells by Bondanza (2003)10.1172/JCI24772
/ J. Clin. Invest. / Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions by Boruchov (2005)10.1084/jem.20031942
/ J. Exp. Med. / Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes by Boule (2004)10.1016/S0896-8411(02)00109-9
/ J. Autoimmun. / Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice by Braun (2003)10.1172/JCI24179
/ J. Clin. Invest. / Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus by Cappione (2005)10.1084/jem.190.6.815
/ J. Exp. Med. / Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity by Casciola-Rosen (1999)10.1182/blood.V90.4.1458
/ Blood / CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis by Caux (1997)10.1084/jem.20050338
/ J. Exp. Med. / Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus by Christensen (2005)10.1073/pnas.0500014102
/ Proc. Natl. Acad. Sci. USA / Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells by Dhodapkar (2005)10.1158/0008-5472.CAN-05-3396
/ Cancer Res. / Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors by Di Pucchio (2006)10.1084/jem.185.5.941
/ J. Exp. Med. / Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes by Dubois (1997)10.4049/jimmunol.161.5.2223
/ J. Immunol. / Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes by Dubois (1998)10.1084/jem.20052438
/ J. Exp. Med. / TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE by Ehlers (2006)10.1016/S0002-9440(10)61689-6
/ Am. J. Pathol. / Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions by Farkas (2001)10.1146/annurev.immunol.19.1.163
/ Annu. Rev. Immunol. / Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? by Feldmann (2001)10.1080/mccm.6.3.149.154
/ Cytokines Cell. Mol. Ther. / Effects of interferon-alpha on peripheral neutrophil counts and serum granulocyte colony-stimulating factor levels in chronic hepatitis C patients by Fukuda (2000)10.1111/j.1365-2133.1991.tb14774.x
/ Br. J. Dermatol. / Psoriasis induced by interferon-alpha by Funk (1991)10.1002/(SICI)1521-4141(199911)29:11<3712::AID-IMMU3712>3.0.CO;2-P
/ Eur. J. Immunol. / Dendritic cells associated with plasmablast survival by Garcia De Vinuesa (1999)10.1016/S0198-8859(02)00756-5
/ Hum. Immunol. / Blood dendritic cells and DC-poietins in systemic lupus erythematosus by Gill (2002)10.1073/pnas.0510837103
/ Proc. Natl. Acad. Sci. USA / Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome by Gottenberg (2006)10.1038/ng1782
/ Nat. Genet. / A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus by Graham (2006)10.1002/ana.20464
/ Ann. Neurol. / Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis by Greenberg (2005)10.1084/jem.185.6.1101
/ J. Exp. Med. / The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand by Grouard (1997)10.1016/S1074-7613(03)00240-1
/ Immunity / Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity by Hanada (2003)10.1084/jem.194.6.769
/ J. Exp. Med. / Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo by Hawiger (2001)10.1016/S1074-7613(00)00064-9
/ Immunity / CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling by Hida (2000)10.1084/jem.170.2.607
/ J. Exp. Med. / Tumor necrosis factor identified in multiple sclerosis brain by Hofman (1989)10.1038/nature03464
/ Nature / IRF-7 is the master regulator of type-I interferon-dependent immune responses by Honda (2005)10.1056/NEJM197907053010102
/ N. Engl. J. Med. / Immune interferon in the circulation of patients with autoimmune disease by Hooks (1979)10.4049/jimmunol.173.3.2134
/ J. Immunol. / Type I IFN protects against murine lupus by Hron (2004)10.1002/art.21890
/ Arthritis Rheum. / Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies by Hua (2006)10.2337/diab.44.6.658
/ Diabetes / Interferon expression in the pancreases of patients with type I diabetes by Huang (1995){'key': '10.1016/j.immuni.2006.08.010_bib47', 'first-page': '24', 'article-title': 'B cell targeted therapies in autoimmune diseases', 'volume': '77', 'author': 'Isenberg', 'year': '2006', 'journal-title': 'J. Rheumatol. Suppl.'}
/ J. Rheumatol. Suppl. / B cell targeted therapies in autoimmune diseases by Isenberg (2006)10.1038/331356a0
/ Nature / Tumour necrosis factor-alpha in murine autoimmune ‘lupus’ nephritis by Jacob (1988)10.4049/jimmunol.165.7.4062
/ J. Immunol. / Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy by Jahnsen (2000)10.1016/S1074-7613(03)00208-5
/ Immunity / Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6 by Jego (2003)10.1084/jem.20050821
/ J. Exp. Med. / Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection by Kolumam (2005)10.1126/science.1125893
/ Science / Regulation of B cell tolerance by the lupus susceptibility gene Ly108 by Kumar (2006)10.1097/01.bor.0000132646.55056.e0
/ Curr. Opin. Rheumatol. / T lymphocytes in systemic lupus erythematosus: an update by Kyttaris (2004)10.1084/jem.20050630
/ J. Exp. Med. / RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement by Lau (2005)10.4049/jimmunol.176.8.4682
/ J. Immunol. / Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming by Le Bon (2006)10.4049/jimmunol.176.4.2074
/ J. Immunol. / Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN by Le Bon (2006)10.1038/416603a
/ Nature / Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors by Leadbetter (2002)10.4049/jimmunol.166.9.5530
/ J. Immunol. / IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells by Levings (2001)10.1172/JCI23587
/ J. Clin. Invest. / Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays by Li (2005)10.1084/jem.187.1.79
/ J. Exp. Med. / Impairment of T and B cell development by treatment with a type I interferon by Lin (1998)10.1038/ni829
/ Nat. Immunol. / DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL by Litinskiy (2002)10.1146/annurev.immunol.23.021704.115633
/ Annu. Rev. Immunol. / IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors by Liu (2005)10.1016/j.clim.2006.01.014
/ Clin. Immunol. / What do mouse models teach us about human SLE? by Liu (2006)10.1038/sj.gene.6364286
/ Genes Immun. / Genomic view of systemic autoimmunity in MRLlpr mice by Liu (2006)10.1126/science.1091334
/ Science / Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria by Macpherson (2004)10.1084/jem.189.3.521
/ J. Exp. Med. / Type I interferons keep activated T cells alive by Marrack (1999)10.1084/jem.20052228
/ J. Exp. Med. / Autoantibodies make a U-turn: the toll hypothesis for autoantibody specificity by Martin (2005)10.4049/jimmunol.174.5.2499
/ J. Immunol. / IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice by Mathian (2005)10.1007/PL00011171
/ Clin. Rheumatol. / Changes of CD4/CD8 ratio and interleukin-16 in systemic lupus erythematosus by Matsushita (2000)10.1172/JCI23025
/ J. Clin. Invest. / Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9 by Means (2005)10.4049/jimmunol.171.7.3385
/ J. Immunol. / IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities by Mohty (2003)10.1146/annurev.iy.07.040189.001045
/ Annu. Rev. Immunol. / TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties by Mosmann (1989)10.1084/jem.20050500
/ J. Exp. Med. / Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production by Nestle (2005)10.1073/pnas.0408506102
/ Proc. Natl. Acad. Sci. USA / Cross-regulation of TNF and IFN-{alpha} in autoimmune diseases by Palucka (2005)10.1681/ASN.2005070714
/ J. Am. Soc. Nephrol. / Toll-like receptor-7 modulates immune complex glomerulonephritis by Pawar (2006)10.1126/science.1124978
/ Science / Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication by Pisitkun (2006)10.1126/science.6176024
/ Science / Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon by Preble (1982)10.1126/science.1125703
/ Science / Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells by Qi (2006)10.3109/02841869109092414
/ Acta Oncol. / Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment by Ronnblom (1991)10.1016/S0165-5728(99)00029-6
/ J. Neuroimmunol. / Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers by Rothuizen (1999)10.1084/jem.20021996
/ J. Exp. Med. / Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice by Santiago-Raber (2003)10.1084/jem.20021343
/ J. Exp. Med. / G-CSF-stimulated neutrophils are a prominent source of functional BLyS by Scapini (2003)10.1111/j.1365-2567.2004.01862.x
/ Immunology / Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells by Sen (2004)10.1191/0961203303lu362xx
/ Lupus / Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration by Shodell (2003)10.1126/science.284.5421.1835
/ Science / The nature of the principal type 1 interferon-producing cells in human blood by Siegal (1999)10.1146/annurev.immunol.21.120601.141040
/ Annu. Rev. Immunol. / Tolerogenic dendritic cells by Steinman (2003)10.1073/pnas.0603912103
/ Proc. Natl. Acad. Sci. USA / From the cover: a Tlr7 translocation accelerates systemic autoimmunity in murine lupus by Subramanian (2006)10.1038/nature03308
/ Nature / Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors by Takaoka (2005)10.4049/jimmunol.168.8.4154
/ J. Immunol. / Gene expression profiling in DQA1∗0501+ children with untreated dermatomyositis: a novel model of pathogenesis by Tezak (2002)10.1016/j.immuni.2004.05.010
/ Immunity / Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches by Thien (2004)10.1046/j.0022-202X.2003.22113.x
/ J. Invest. Dermatol. / In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered by van der Fits (2004)10.1016/j.febslet.2005.09.089
/ FEBS Lett. / Interactions of DC-SIGN with Mac-1 and CEACAM1 regulate contact between dendritic cells and neutrophils by van Gisbergen (2005)10.1046/j.1365-2249.2001.01623.x
/ Clin. Exp. Immunol. / HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus by Viallard (2001)10.1038/nature03555
/ Nature / A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity by Vinuesa (2005)10.1084/jem.20051696
/ J. Exp. Med. / Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8 by Vollmer (2005)10.1002/art.21553
/ Arthritis Rheum. / Toll-like receptor 9 signaling protects against murine lupus by Wu (2006)10.4049/jimmunol.161.3.1313
/ J. Immunol. / Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response by Wykes (1998)10.1002/art.10112
/ Arthritis Rheum. / Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis by Yamada (2002)10.1126/science.286.5439.525
/ Science / Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 by Yang (1999)10.1084/jem.20042251
/ J. Exp. Med. / Defective B cell tolerance checkpoints in systemic lupus erythematosus by Yurasov (2005)
Dates
Type | When |
---|---|
Created | 18 years, 11 months ago (Sept. 20, 2006, 7:42 a.m.) |
Deposited | 1 year, 6 months ago (Feb. 6, 2024, 10:30 a.m.) |
Indexed | 1 day, 13 hours ago (Sept. 4, 2025, 10:25 a.m.) |
Issued | 19 years ago (Sept. 1, 2006) |
Published | 19 years ago (Sept. 1, 2006) |
Published Print | 19 years ago (Sept. 1, 2006) |
@article{Banchereau_2006, title={Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases}, volume={25}, ISSN={1074-7613}, url={http://dx.doi.org/10.1016/j.immuni.2006.08.010}, DOI={10.1016/j.immuni.2006.08.010}, number={3}, journal={Immunity}, publisher={Elsevier BV}, author={Banchereau, Jacques and Pascual, Virginia}, year={2006}, month=sep, pages={383–392} }